Does CC-4047 Cause Pancytopenia? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Pancytopenia have been filed in association with CC-4047. This represents 4.4% of all adverse event reports for CC-4047.
5
Reports of Pancytopenia with CC-4047
4.4%
of all CC-4047 reports
1
Deaths
4
Hospitalizations
How Dangerous Is Pancytopenia From CC-4047?
Of the 5 reports, 1 (20.0%) resulted in death, 4 (80.0%) required hospitalization, and 2 (40.0%) were considered life-threatening.
Is Pancytopenia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CC-4047. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does CC-4047 Cause?
Plasma cell myeloma (42)
Death (13)
Neutropenia (10)
Thrombocytopenia (10)
Anaemia (8)
Pneumonia (8)
Leukopenia (6)
Febrile neutropenia (5)
Neutrophil count decreased (5)
Renal failure acute (5)
What Other Drugs Cause Pancytopenia?
METHOTREXATE (5,377)
CYCLOPHOSPHAMIDE (3,351)
CARBOPLATIN (2,910)
RITUXIMAB (2,400)
LENALIDOMIDE (2,259)
DOXORUBICIN (2,212)
VINCRISTINE (2,180)
ETOPOSIDE (2,129)
DEXAMETHASONE (2,053)
PREDNISONE (1,743)
Which CC-4047 Alternatives Have Lower Pancytopenia Risk?
CC-4047 vs CEDAZURIDINE\DECITABINE
CC-4047 vs CEDIRANIB
CC-4047 vs CEFACLOR
CC-4047 vs CEFADROXIL
CC-4047 vs CEFAZOLIN